Patent · US Active

Cyclic peptide compounds

US8252895B2 · kind B2 · utility

0Cited by
1References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 21, 2010
Grant dateAug 28, 2012
Priority date
Expiry dateNov 26, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a new cyclic peptide compound or a salt thereof, which has anti-hepatitis C virus activities based on inhibitory activity against the RNA replication of hepatitis C virus replicon, to a process for preparation thereof comprising a rearrangement reaction under a mild acidic condition and the following amino acid changing reactions etc., to a pharmaceutical composition comprising the same, and to a method for prophylactic and/or therapeutic treatment of hepatitis C in a human being or an animal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.